Closed Systems Transfer Devices Companies

The closed system transfer devices market (CSTD) is projected to reach USD 2.09 billion by 2030 from USD 1.49 billion in 2025, at a CAGR of 7.0% during the forecast period.

Market growth is driven primarily by increased interest in the safety of healthcare workers, especially from exposure to harmful cancer drugs during treatment. Tougher regulations requiring safe handling practices have given impetus to the adoption of CSTDs. Demand for these devices is driven further by increased disease rates such as cancer and increased use of strong medications in targeted medicine. The implementation of CSTDs in hospitals and oncology facilities is hindered by the initial installation cost, organizational change resistance, the slow pace of technology adoption, regulatory complexity, and compliance issues.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the closed system transfer device market are BD (US), ICU Medical, Inc. (US), B Braun Melsungen AG (Germany),  Corvida Medical (US), JMS Co. Ltd. (Japan), EQUASHIELD (US), Corning Incorporated (US), Terumo Corporation (Japan), Cardinal Health (US), Baxter (US), and West Pharmaceuticals Services, Inc. (US), among others. These players have adopted various growth strategies such as product launches, acquisitions, and expansion to increase their presence and reach in the closed system transfer devices market.

ICU Medical, Inc. has a comprehensive portfolio for the safe handling of dangerous IV medications. Its range of products includes automated and needleless drug compounding systems. The company is engaged in a long-term supply deal with Terumo Corporation (Japan) to distribute its products throughout Japan and Asia, including IV therapy and CSTD products. Over the last three years, the company's infusion consumables segment has grown steadily, taking up the highest share of 37% of the total revenue mix.

BD has a broad product portfolio, including hazardous drug-safe devices such as the PhaSeal and Texium system. It has a global presence spanning more than 50 countries. The BD PhaSeal system works with a wide range of chemotherapeutic medications. It is more widely used in the US and other markets than other CSTDs.

EQUASHIELD provides nursing tubing sets, connectors, closed syringes, and adapters for using vials and IV bags in pharmacies. It uses a global network of distributors to distribute and offer services to clients on four continents outside of the US. It offers Equashield I, II, its flagship CSTD, and Equashield Pro, a system-enabled multi-station hazardous IV drug compounder. The company has expanded its presence, including Brazil, the Netherlands, and the UK, in the past three years.

Market Ranking

The closed system transfer devices market is characterized by high market consolidation by the top players. With the increasing adoption of automated drug compounding and reconstitution systems, this market is expected to grow in the coming years. Moreover, a few market players have started offering CSTDs integrated with prefilled syringes, thereby limiting contact with hazardous drugs. Such practices are expected to broaden the scope and utility of CSTDs in the future. The ranking of companies in the market has been determined through a market share analysis conducted after thorough secondary research and validated by primary respondents. This ranking considers parameters such as revenue generated from CSTD, product portfolio breadth and depth, innovation, and approvals and launches. Based on this analysis, the top three players leading the market are ICU Medical, Inc. (US), BD (US), and EQUASHIELD (US). These companies dominate due to their strong presence, extensive product portfolios, and continuous innovations in the closed system transfer devices market.

Related Reports:

Closed Systems Transfer Devices Market by Closing Mechanism (Color-to-Color Systems), Type (Needleless Systems), Component (Female Components, Male Luers), Technology (Air Cleaning/Filtration Devices), End User (Hospitals & Clinics) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com